Raymond Tice
Overview
Explore the profile of Raymond Tice including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richard A, Tao D, LeClair C, Leister W, Tretyakov K, White 5th E, et al.
Chem Res Toxicol
. 2025 Jan;
38(1):15-41.
PMID: 39829241
The analytical quality of compounds subjected to high-throughput screening (HTS) impacts accurate interpretation of assay results, with poor quality samples potentially leading to false negatives or positives. The Tox21 "10K"...
2.
Filonov D, Tice R, Luo R, Grotegut C, Van Kanegan M, Ludlow J, et al.
Front Public Health
. 2019 Jan;
6:369.
PMID: 30622937
There is increased interest in using high throughput assays to characterize human population variability in response to toxicants and drugs. Utilizing primary human endothelial colony-forming cells (ECFCs) isolated from blood...
3.
Behrsing H, Hill E, Raabe H, Tice R, Fitzpatrick S, Devlin R, et al.
Altern Lab Anim
. 2017 Aug;
45(3):117-158.
PMID: 28816053
In 2009, the passing of the Family Smoking Prevention and Tobacco Control Act facilitated the establishment of the FDA Center for Tobacco Products (CTP), and gave it regulatory authority over...
4.
Malloy T, Zaunbrecher V, Beryt E, Judson R, Tice R, Allard P, et al.
Integr Environ Assess Manag
. 2017 Mar;
13(5):915-925.
PMID: 28247928
Alternatives analysis (AA) is a method used in regulation and product design to identify, assess, and evaluate the safety and viability of potential substitutes for hazardous chemicals. It requires toxicological...
5.
Tice R
Mutat Res Genet Toxicol Environ Mutagen
. 2015 Jul;
786-788:1.
PMID: 26212291
No abstract available.
6.
Zeiger E, Gollapudi B, Aardema M, Auerbach S, Boverhof D, Custer L, et al.
Environ Mol Mutagen
. 2014 Dec;
56(3):277-85.
PMID: 25482136
Genetic toxicity tests currently used to identify and characterize potential human mutagens and carcinogens rely on measurements of primary DNA damage, gene mutation, and chromosome damage in vitro and in...
7.
Khare T, Pai S, Koncevicius K, Pal M, Kriukiene E, Liutkeviciute Z, et al.
Nat Struct Mol Biol
. 2012 Sep;
19(10):1037-43.
PMID: 22961382
The 5-methylcytosine (5-mC) derivative 5-hydroxymethylcytosine (5-hmC) is abundant in the brain for unknown reasons. Here we characterize the genomic distribution of 5-hmC and 5-mC in human and mouse tissues. We...
8.
Parham F, Austin C, Southall N, Huang R, Tice R, Portier C
J Biomol Screen
. 2009 Oct;
14(10):1216-27.
PMID: 19828774
The National Toxicology Program is developing a high-throughput screening (HTS) program to set testing priorities for compounds of interest, to identify mechanisms of action, and potentially to develop predictive models...
9.
Jacobson-Kram D, Mattison D, Shelby M, Slikker W, Tice R, Witt K
Cancer Lett
. 2007 Dec;
260(1-2):216-8.
PMID: 18055105
No abstract available.
10.
Balls M, Amcoff P, Bremer S, Casati S, Coecke S, Clothier R, et al.
Altern Lab Anim
. 2007 Feb;
34(6):603-20.
PMID: 17266393
No abstract available.